Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FPLLA-PETHEMA-001: Study of Prognostic Factors in Adult Lymphoblastic Lymphoma

NCT03571997 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT03571997
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03571997 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FPLLA-PETHEMA-001: Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
Lead sponsor
PETHEMA Foundation
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2018
Completion date
December 30, 2022
Enrollment
30 (estimated)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoblastic lymphoma